NG11-1 - VasoDynamics

NG11 Prevention and Reduction Of Radiation – induced Oral Mucositis (RIOM)

VasoDynamics submits UK Clinical Trial Application for NG11-2
Gallery

VasoDynamics submits UK Clinical Trial Application for NG11-2

By Chloe Atkinson|2024-11-13T13:00:58+00:00October 21st, 2022|Clinical Development, News, NG11|

VasoDynamics files global patent (PCT) for NG11-2 platform formulation and production
Gallery

VasoDynamics files global patent (PCT) for NG11-2 platform formulation and production

By Chloe Atkinson|2024-11-13T13:01:41+00:00March 5th, 2022|Clinical Development, News, NG11|

VasoDynamics completes MHRA advisory meeting for NG11-2 clinical development
Gallery

VasoDynamics completes MHRA advisory meeting for NG11-2 clinical development

By Chloe Atkinson|2024-11-13T13:02:35+00:00September 21st, 2021|Clinical Development, News, NG11|